Evidence mapPaperPMID 41735876Full record

ReviewBMC nephrology2026

Bridging systems: oral-kidney connections - pathophysiological links, clinical implications, and health system integration - a narrative review.

Priyanka Gudsoorkar, C Elena Cervantes, Isabella Lerma, Anay Dudhbhate, Sujay A J Mehta, Ramprasad Vasthare, Edgar Lerma, Lakshman Samaranayake, Prakash Gudsoorkar

Abstract readReview
In one paragraph

Review in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Priyanka GudsoorkarDepartment of Environmental & Public Health Sciences, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
C Elena CervantesDivision of Nephrology, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Isabella LermaMarquette University, Milwaukee, Wisconsin, USA.
Anay DudhbhateTrillium Health Partners, Mississauga, Ontario, Canada.
Sujay A J MehtaVancouver Orofacial Pain, Vancouver, British Columbia, Canada.
Ramprasad VasthareDepartment of Public Health Dentistry, Manipal College of Dental Sciences, Manipal Academy of Higher Education, Udupi, Karnataka, India.
Edgar LermaSection of Nephrology, Advocate Christ Medical Center, Oak Lawn, Illinois, USA.
Lakshman SamaranayakeThe University of Hong Kong, Hong Kong, Hong Kong.
Prakash GudsoorkarDepartment of Medicine, Division of Nephrology, University of Cincinnati, 231 Albert Sabin Way, ML 0585, Room 6255, Cincinnati, Ohio, 45267, USA. gudsoops@ucmail.uc.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emerging evidence supports a bidirectional relationship between chronic kidney disease (CKD) and oral diseases, mediated by systemic inflammation, endothelial dysfunction, and immune dysregulation. Periodontitis and caries are prevalent yet underrecognized contributors to the inflammatory burden in CKD, particularly in low-resource settings where oral and kidney care remain fragmented. This reviewsynthesizes clinical, epidemiologic, and mechanistic evidence fromobservational studies, interventional trials, and meta-analyses examiningoral–renal interactions. PubMed-indexed literature was analyzed to map oralhealth indices, stage-specific manifestations, and the impact of periodontaltherapy on systemic biomarkers in CKD. Across multipleclinical studies, oral disease severity increases in parallel with CKDprogression and systemic inflammation. Elevated dental indices, includingdecayed, missing, and filled teeth (DMFT), plaque index, gingival index, andclinical attachment loss, correlate with reduced glomerular filtration rate andincreased inflammatory markers such as C-reactive protein and interleukin-6. Non-surgical periodontal therapy modestly improves inflammatory profiles,though renal outcomes remain variable. Post-transplant populations exhibitunique oral complications, including gingival overgrowth, candidiasis, andmucosal neoplasia, linked to immunosuppressive regimens. Oral healthconstitutes a measurable and modifiable determinant in CKD progression.Integrating oral assessments into nephrology care can enhance the monitoring ofsystemic inflammation and improve patient quality of life. Structuralinequities and limited workforce capacity continue to impede global oral–renalintegration. Evidence-based, interdisciplinary strategies are proposed to embedoral health within CKD management pathways.

Indexed as

KidneyMouth DiseasesRenal Insufficiency, ChronicHumansInflammationOral HealthChronic kidney disease (CKD)Integrated care modelsOral–kidney axisPeriodontitisSystemic inflammation

Identifiers

PMID41735876
PMCPMC13037270

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.